XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series F Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2021 79,246 0 3,280,750      
Balance at Dec. 31, 2021 $ 792 $ 0 $ 32,808 $ 168,272,366 $ (128,040,282) $ 40,265,684
Shares issued to consultant and other 0 0 $ 86 162,036 0 162,122
Shares issued to consultant and other (in shares)     8,595      
Vesting expense $ 0 $ 0 $ 0 36,518 0 36,518
Net loss     $ 0 0 (3,370,715) (3,370,715)
Balance (in shares) at Mar. 31, 2022 79,246 0 3,295,345      
Balance at Mar. 31, 2022 $ 792 $ 0 $ 32,954 168,557,745 (131,410,997) 37,180,494
Shares issued pursuant to equity line   $ 0   86,825 0 86,885
Shares issued pursuant to equity line (in shares)     6,000      
Balance (in shares) at Dec. 31, 2022 79,246 0 3,938,160      
Balance at Dec. 31, 2022 $ 792 $ 0 $ 39,382 175,503,634 (153,777,916) 21,765,892
Shares issued to consultant and other 0 0 $ 318 200,690 0 201,008
Shares issued to consultant and other (in shares)     31,833      
Vesting expense $ 0 $ 0 $ 0 9,287 0 9,287
Series F preferred stock dividend (in shares) 0 79,404 0      
Series F preferred stock dividend $ 0 $ 794 $ 0 (794) 0 0
Net loss     $ 0 0 (3,421,802) (3,421,802)
Balance (in shares) at Mar. 31, 2023 79,246 79,404 3,969,993      
Balance at Mar. 31, 2023 $ 792 $ 794 $ 39,700 $ 175,712,817 $ (157,199,718) $ 18,554,385